Open Access Open Access  Restricted Access Subscription Access

Comparative Analysis of Baseline and One Year Post HAART Haematological Parameters of HIV Infected Patients in Ilorin, Nigeria


Affiliations
1 Department of Haematology, University of Ilorin, Ilorin, Nigeria
2 Department of Haematology, Federal Medical Centre, Gusau, Nigeria
3 Department of Haematology and Blood Transfusion, University of Ilorin Teaching Hospital, Ilorin, Nigeria
4 Department of Haematology, LAUTECH Teaching Hospital, Ogbomoso, Nigeria
5 Department of Haematology, Sobi Specialist Hospital, Ilorin, Nigeria
 

Haematological abnormalities are common manifestations of HIV infection. The aim of this study was to determine the effect of HAART on haematological parameters of HIV infected patients.This was a longitudinal prospective study conducted at the HAART clinic of University of Ilorin Teaching Hospital, Ilorin. Eighty newly diagnosed HIV positive patients between 21-75 years who were planned to commence HAART (lamivudine, zidovudine and nevirapine) were recruited into this study. Baseline and one year post-HAART full blood count were carried out by Sysmex KX21 according to manufacturer’s instructions.Twenty nine percent of the patients had anaemia, 13% had neutropaenia and 0.02% had thrombocytopaenia at presentation. There was a significant increase in mean hemoglobin concentration of the patients from 10.79±1.89g/dl at baseline to 11.52±1.27g/dl at one year post HAART initiation. (P value=0.003) There was a statistically significant difference in mean baseline haemoglobin concentration of patients in WHO clinical stages 1, 2 and 3(11.67±1.39g/dl, 10.47±2.09g/dl, 10.00±1.86g/dl respectively; P=0.012). HIV patients were more likely to present with anaemia followed by neutropaenia and rarely thrombocytopaenia. Severity of anaemia increased with disease progression. HAART led to improvement in haematological abnormalities with significant increase in haemoglobin concentration. Haemoglobin concentration may therefore be used to monitor response to HAART in HIV infected patients.

Keywords

HIV, Haematological Parameters, HAART.
User
Notifications
Font Size

  • National Agency for the control of AIDS(NACA)(2014) Global AIDS Response country Progress Report. Abuja, Nigeria. www unaidorg.
  • Costello, C (2005) Haematology in HIV Disease. In: Hoffbrand A, Catovsky D, Edward G, editors. Postgraduate Haematology Massachusetts , USA: Blackwell publisher,380-394.
  • Shafer, RW and Vuitton DA (1999) Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1. Biomedicine & pharmacotherapy. 53(2),73-86.
  • Palmer, C (2003)HIV treatments and highly active antiretroviral therapy. Australian
  • Idowu CO, Oke OT, Afolayan DO, Olanira O, Akinloye OA and Awodumila OO. (2013) Effect of HAART on some haematological parameters,correlations between total lymphocyte and CD4 counts of HIV clients attending ssh, ikole-ekiti. Int J Biol Med Res. 4(3), 3265-3270.
  • Kibaru EG, Nduati R, Wamalwa D and Kariuki N. (2015) Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective study. AIDS research and therapy.12(26),1-8.
  • Subbaraman R, Chaguturu SK, Mayer KH, Flanigan TP and Kumarasamy N. (2007) Adverse effects of highly active antiretroviral therapy in developing countries. Clinical Infectious Diseases.45(8),1093-1101.
  • Denue BA, Kida IM, Hammagabdo A, Dayar A and Sahabi, MA. (2013) Prevalence of anemia and immunological markers in HIV-infected patients on highly Active antiretroviral therapy in Northeastern Nigeria. Infectious Diseases: Research and Treatment. 6,25-33.
  • Abdulrahaman Y, Yeldu MH, Zama II and Aminu A. (2014) Some haematological profile of HIV/AIDS patients on Highly Active Antiretroviral Therapy (HAART) in Usmanu Danfodiyo University Teaching Hospital Sokoto, North Western Nigeria. Journal of Science and Technology. 2(1),27-32.
  • Parinitha SS and Kulkarni MH. (2012) Haematological changes in HIV infection with correlation to CD4 cell count. Australasian Medical Journal. 5(3),157-162.
  • Vanisri HR and Vadiraja N. (2016)Hematological outline in HIV infection in relation to CD4 cell count, a hospital based study. Indian Journal of Pathology and Oncology. 3(2),260-263.
  • Enawgaw B, Alem M, Addis Z and Melku M. (2014) Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naive in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study. BMC hematology. 14(8), 1-7.
  • De Santis GC, Brunetta DM, Vilar FC et al. (2011)Hematological abnormalities in HIV-infected patients. International Journal of Infectious Diseases. 15(12),e808-e811.
  • Kuritzkes DR. (2000) Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor. Clinical Infectious Diseases. 30(2), 256-270.
  • Moses AV, Williams S, Heneveld ML, Strussenberg J, Rarick M, Loveless M, Bagby G and Nelson, JA. (1996) Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors Blood. 87(3), 919-925.
  • Kitahata MM, Gange SJ, braham AG, Merriman B, Saag MS and Justice, AC. (2009) Effect of early vs deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine. 360, 1815-1826.

Abstract Views: 576

PDF Views: 170




  • Comparative Analysis of Baseline and One Year Post HAART Haematological Parameters of HIV Infected Patients in Ilorin, Nigeria

Abstract Views: 576  |  PDF Views: 170

Authors

Olawumi Hannah Oluwayemisi
Department of Haematology, University of Ilorin, Ilorin, Nigeria
Babatunde Abiola Samuel
Department of Haematology, University of Ilorin, Ilorin, Nigeria
Adepoju Ayodeji Majeed
Department of Haematology, Federal Medical Centre, Gusau, Nigeria
Omokanye Khadijat Olaitan
Department of Haematology and Blood Transfusion, University of Ilorin Teaching Hospital, Ilorin, Nigeria
Jaiyeola Aminah Ayokunnu
Department of Haematology and Blood Transfusion, University of Ilorin Teaching Hospital, Ilorin, Nigeria
Ogunfemi Mutiat Kehinde
Department of Haematology and Blood Transfusion, University of Ilorin Teaching Hospital, Ilorin, Nigeria
Oladosu-Olayiwola Oluwatosin Rashidat
Department of Haematology, LAUTECH Teaching Hospital, Ogbomoso, Nigeria
A. Sani Musa
Department of Haematology, Sobi Specialist Hospital, Ilorin, Nigeria

Abstract


Haematological abnormalities are common manifestations of HIV infection. The aim of this study was to determine the effect of HAART on haematological parameters of HIV infected patients.This was a longitudinal prospective study conducted at the HAART clinic of University of Ilorin Teaching Hospital, Ilorin. Eighty newly diagnosed HIV positive patients between 21-75 years who were planned to commence HAART (lamivudine, zidovudine and nevirapine) were recruited into this study. Baseline and one year post-HAART full blood count were carried out by Sysmex KX21 according to manufacturer’s instructions.Twenty nine percent of the patients had anaemia, 13% had neutropaenia and 0.02% had thrombocytopaenia at presentation. There was a significant increase in mean hemoglobin concentration of the patients from 10.79±1.89g/dl at baseline to 11.52±1.27g/dl at one year post HAART initiation. (P value=0.003) There was a statistically significant difference in mean baseline haemoglobin concentration of patients in WHO clinical stages 1, 2 and 3(11.67±1.39g/dl, 10.47±2.09g/dl, 10.00±1.86g/dl respectively; P=0.012). HIV patients were more likely to present with anaemia followed by neutropaenia and rarely thrombocytopaenia. Severity of anaemia increased with disease progression. HAART led to improvement in haematological abnormalities with significant increase in haemoglobin concentration. Haemoglobin concentration may therefore be used to monitor response to HAART in HIV infected patients.

Keywords


HIV, Haematological Parameters, HAART.

References